Simplex Trading’s ProShares Ultra CRCL CRCA Stock Holding History

Simplex Trading’s Portfolio CRCA Stock Details CRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$201K	Buy	4,865 +4,433	+1,026%	+$184K	﹤0.01%	4292
2025 Q4	$17.5K	Sell	432 -441	-51%	-$37.8K	﹤0.01%	6599
2025 Q3	$127K	Buy	+873	New	+$141K	﹤0.01%	5483

Other funds holding CRCA

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading's CRCA Position: Q1 2026 in Review

Simplex Trading increased its ProShares Ultra CRCL (CRCA) stake by 1,026% in Q1 2026, buying an estimated $184K and bringing the position to 4,865 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #4292.

Simplex Trading first reported a position in CRCA in Q3 2025 and has held it in 3 quarters since. 7 funds tracked by Wall St. Rank hold CRCA as of Q1 2026.

Simplex Trading held 4,865 shares of ProShares Ultra CRCL worth $201K as of Q1 2026.
Simplex Trading bought 4,433 ProShares Ultra CRCL shares in Q1 2026, an estimated $184K.
ProShares Ultra CRCL made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4292 holding.
Simplex Trading first reported a position in ProShares Ultra CRCL in Q3 2025 and has held it in 3 quarters since.
7 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.